Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20049949rdf:typepubmed:Citationlld:pubmed
pubmed-article:20049949lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C0009324lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C0127615lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C0544452lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C0524527lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:20049949lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:20049949pubmed:issue9lld:pubmed
pubmed-article:20049949pubmed:dateCreated2010-8-30lld:pubmed
pubmed-article:20049949pubmed:abstractTextMesalamine has been used as the first-line medication for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two different mesalamine formulations in the maintenance of remission in patients with UC.lld:pubmed
pubmed-article:20049949pubmed:languageenglld:pubmed
pubmed-article:20049949pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20049949pubmed:citationSubsetIMlld:pubmed
pubmed-article:20049949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20049949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20049949pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20049949pubmed:statusMEDLINElld:pubmed
pubmed-article:20049949pubmed:monthSeplld:pubmed
pubmed-article:20049949pubmed:issn1536-4844lld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:ItoHiroakiHlld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:MatsumotoTaka...lld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:IidaMitsuoMlld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:SuzukiYasuoYlld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:HibiToshifumi...lld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:TakanoYuichiYlld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:YoshidaToyomi...lld:pubmed
pubmed-article:20049949pubmed:authorpubmed-author:AidaYoshiyuki...lld:pubmed
pubmed-article:20049949pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20049949pubmed:volume16lld:pubmed
pubmed-article:20049949pubmed:ownerNLMlld:pubmed
pubmed-article:20049949pubmed:authorsCompleteYlld:pubmed
pubmed-article:20049949pubmed:pagination1575-82lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:meshHeadingpubmed-meshheading:20049949...lld:pubmed
pubmed-article:20049949pubmed:year2010lld:pubmed
pubmed-article:20049949pubmed:articleTitleDirect comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study.lld:pubmed
pubmed-article:20049949pubmed:affiliationDigestive Disease Center of Excellence, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka, Japan.lld:pubmed
pubmed-article:20049949pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20049949pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20049949pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20049949pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20049949pubmed:publicationTypeMulticenter Studylld:pubmed